Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)

drug protocol number
107402
drug sponsor
Gsk
drug study
Meningococcal ACWY Conjugate Vaccine
drug trial site
NGHA-R
drug status
Completed
drug phase